Panagora Asset Management Inc Alpine Immune Sciences, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$6.84 - $11.91 $84,774 - $147,612	12,394 New	12,394 $127,000
Q3 2019 Nov 12, 2019	SELL	$3.5 - $5.0 $21,147 - $30,210	-6,042 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$4.08 - $7.75 $1,064 - $2,022	-261 Reduced 4.14%	6,042 $25,000
Q1 2019 May 15, 2019	SELL	$4.09 - $7.19 $1,791 - $3,149	-438 Reduced 6.5%	6,303 $43,000
Q4 2018 Feb 14, 2019	SELL	$3.68 - $6.07 $467 - $770	-127 Reduced 1.85%	6,741 $25,000
Q3 2018 Nov 13, 2018	SELL	$5.68 - $8.59 $13,603 - $20,573	-2,395 Reduced 25.86%	6,868 $43,000
Q2 2018 Aug 14, 2018	BUY	$7.16 - $10.05 $10,024 - $14,070	1,400 Added 17.8%	9,263 $70,000
Q4 2017 Feb 14, 2018	BUY	$9.65 - $12.65 $75,877 - $99,466	7,863	7,863 $88,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.